VDAC1 Antibodies

Santa Cruz Biotechnology features a diverse variety of VDAC1 monoclonal antibodies for research focused on understanding Voltage-Dependent Anion Channel 1 (VDAC1) in cellular processes. VDAC1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VDAC1 is a crucial protein located in the outer mitochondrial membrane, playing a significant role in regulating mitochondrial metabolism and apoptosis. It serves as a channel for the transport of ions and metabolites, thereby influencing cellular energy production and signaling pathways. Research on VDAC1 continues to reveal its importance in various diseases, including cancer and neurodegenerative disorders. VDAC1 monoclonal antibodies enable precise detection and analysis of protein expression, localization, and interactions in diverse experimental settings. Understanding VDAC1's role in mitochondrial function has opened new avenues for therapeutic interventions in multiple disease states. Ongoing studies of VDAC1 contribute significantly to our knowledge of cellular metabolism and cell death mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of VDAC1's role in health and disease.